Trademark: 88221050
Word
NOVOCOL PHARMA
Status
Pending
Status Code
774
Status Date
Wednesday, October 4, 2023
Serial Number
88221050
Mark Type
4000
Filing Date
Friday, December 7, 2018
Published for Opposition
Tuesday, June 6, 2023

Trademark Owner History
Septodont Holding SAS - Owner At Publication

Classifications
40 Contract manufacturing of clinical batches of pharmaceuticals; Consulting services relating to pharmaceutical manufacturing, batch biological treatment batches, and pharmaceutical manufacturing; custom manufacture of pharmaceuticals, namely, the formulation of new dosage forms and the reformulation of existing drug products
5 Pharmaceutical preparations, namely, acne medication, allergy medication, antacids, anthelmintics, antiarrhythmics, antibiotic creams and ointments, antibiotics, anticoagulants, anticonvulsants, antidepressants, antiemetics, antiflatulants, antihistamines, antihypertensives anti-infectives, anti-inflammatories, antiparasites, antivirals, burn relief medication, calcium channel blockers, central nervous system depressants, central nervous system stimulants, cough treatment medication, diarrhea medication, fungal medications, gastro-intestinal pharmaceutical preparations, glaucoma agents, hydrocortisone, hypnotic agents, sedatives, pain relief medication, and topical and injectable pharmaceutical preparations for dental, endodontic and periodontal disorders; anti-epileptic pharmaceutical preparations; bismuth preparations for pharmaceutical use; bromine for pharmaceutical purposes; cardiovascular pharmaceutical preparations; frostbite salve for pharmaceutical purposes; guaiacol for pharmaceutical purposes; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; injectable pharmaceutical contraceptives; pharmaceutical anti-allergic preparations and substances; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for reducing cholesterol; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders; pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue; pharmaceutical preparations for the treatment of drug and alcohol abuse; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely, infertility, sexually transmitted diseases, incontinence and sexual dysfunction; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of glaucoma; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of metabolic disorders, namely, bulimia nervosa, anorexia, and hypothyroidism; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of motion sickness; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of myalgia and neuralgia; pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; pharmaceutical preparations for the treatment of psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections; pharmaceutical preparations for the treatment of skin irritations, namely, bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for the treatment of smoking cessation; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system, namely, brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of varicose veins; pharmaceutical preparations for the treatment of vascular diseases; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating asthma; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in discouraging the smoking habit; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for wounds; pharmaceutical preparations against dry skin caused by pregnancy; pharmaceutical preparations for hydrating the skin during pregnancy; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for treating respiratory diseases; pharmaceutical solutions used in dialysis; radioactive pharmaceutical preparations for in vivo diagnostic or therapeutic use; sunburn preparations for pharmaceutical purposes; synthetic peptides for the treatment of all of the foregoing diseases and conditions; disinfection systems, namely, all-purpose disinfectants
35 Business consulting services relating to pharmaceutical manufacturing, clinical evaluation and testing, regulatory registration, stability studies, method development, formal stability, registration batches and commercial production; clinical trial services, namely, business and information management of clinical studies to fast track drug products to market
45 Consulting services to assist companies with obtaining regulatory compliance and licenses for pharmaceuticals and medical devices; Consulting services relating to pharmaceuticals relating to regulatory compliance in the field of pharmaceuticals, namely, regulatory registration
10 Drug delivery systems, namely, needles, syringes, nasal spray bottles, injection devices, oral and nasal inhalation devices, patch pumps, and anesthetic delivery apparatus for medical purposes, but not for use in the fields of diabetes and obesity
42 Consulting services relating to the clinical testing, inspection, or research of pharmaceuticals; Consulting services relating to conducting pharmaceutical stability studies and formal stability studies; Consulting services relating to the development of chemical production methods; Consulting services relating to registration batch research and commercial pharmaceutical products development; Pharmaceutical drug development services, namely, the formulation of new dosage forms and the reformulation of existing drug products; conducting clinical trials for others, namely, managing clinical studies to fast track drug products to market
NOVOCOL PHARMACY
"PHARMA"

Trademark Events
Oct 4, 2023
Opposition Instituted No. 999999
Jun 26, 2023
Extension Of Time To Oppose Received
Jun 6, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 6, 2023
Published For Opposition
May 17, 2023
Notification Of Notice Of Publication E-Mailed
Apr 28, 2023
Approved For Pub - Principal Register
Apr 26, 2023
Teas/Email Correspondence Entered
Apr 26, 2023
Correspondence Received In Law Office
Apr 25, 2023
Assigned To Lie
Apr 18, 2023
Teas Response To Suspension Inquiry Received
Jan 20, 2023
Notification Of Inquiry As To Suspension E-Mailed
Jan 20, 2023
Inquiry To Suspension E-Mailed
Jan 20, 2023
Suspension Inquiry Written
Jan 18, 2023
Suspension Checked ¿ To Attorney For Action
May 23, 2022
Notification Of Letter Of Suspension E-Mailed
May 23, 2022
Letter Of Suspension E-Mailed
May 23, 2022
Suspension Letter Written
May 18, 2022
Teas/Email Correspondence Entered
May 18, 2022
Correspondence Received In Law Office
May 17, 2022
Teas Response To Suspension Inquiry Received
Mar 1, 2022
Teas Change Of Correspondence Received
Mar 1, 2022
Teas Change Of Domestic Representatives Address
Mar 1, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 1, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 23, 2021
Notification Of Inquiry As To Suspension E-Mailed
Nov 23, 2021
Inquiry To Suspension E-Mailed
Nov 23, 2021
Suspension Inquiry Written
Nov 18, 2021
Suspension Checked ¿ To Attorney For Action
May 17, 2021
Notification Of Letter Of Suspension E-Mailed
May 17, 2021
Letter Of Suspension E-Mailed
May 17, 2021
Suspension Letter Written
May 17, 2021
Teas/Email Correspondence Entered
May 17, 2021
Correspondence Received In Law Office
May 14, 2021
Teas Response To Suspension Inquiry Received
Nov 30, 2020
Notification Of Inquiry As To Suspension E-Mailed
Nov 30, 2020
Inquiry To Suspension E-Mailed
Nov 30, 2020
Suspension Inquiry Written
Nov 13, 2020
Suspension Checked ¿ To Attorney For Action
Nov 2, 2020
Assigned To Lie
Feb 28, 2020
Notification Of Letter Of Suspension E-Mailed
Feb 28, 2020
Letter Of Suspension E-Mailed
Feb 28, 2020
Suspension Letter Written
Feb 11, 2020
Teas/Email Correspondence Entered
Feb 11, 2020
Correspondence Received In Law Office
Feb 11, 2020
Teas Response To Suspension Inquiry Received
Sep 3, 2019
Notification Of Letter Of Suspension E-Mailed
Sep 3, 2019
Letter Of Suspension E-Mailed
Sep 3, 2019
Suspension Letter Written
Aug 13, 2019
Teas/Email Correspondence Entered
Aug 13, 2019
Correspondence Received In Law Office
Aug 13, 2019
Teas Response To Office Action Received
Mar 13, 2019
Notification Of Non-Final Action E-Mailed
Mar 13, 2019
Non-Final Action E-Mailed
Mar 13, 2019
Non-Final Action Written
Mar 7, 2019
Assigned To Examiner
Dec 30, 2018
New Application Office Supplied Data Entered
Dec 11, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24